Gregory Zugates Email

VP Research . PureTech Health

Current Roles

Employees:
146
Revenue:
$28.3M
About
PureTech Health (LSE: PRTC) is an advanced, clinical-stage biopharmaceutical company developing novel medicines around the Brain-Immune-Gut (BIG) Axis. The Company has developed deep insight into the connection between these systems and the resulting role in many chronic diseases, which represent the majority of healthcare spend and have proven resistant to established therapeutic approaches. By harnessing this emerging field of human biology, PureTech Health has developed new categories of medicines with the potential to have great impact on people with serious diseases. PureTech Health is advancing a rich pipeline of innovative therapies across two divisions. Its Affiliates division includes two product candidates that are preparing for potential regulatory approval in the United States and Europe and a number of clinical and pre-clinical programmes. These affiliates have developed ground-breaking platforms and therapeutic candidates in collaboration with some of the world's leading scientific experts. PureTech's Internal division is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. These programmes build on a new understanding of the trafficking and biodistribution of various immune system components in order to develop targeted therapies for diseases with major unmet needs including cancer and autoimmune and neuroimmune disorders. For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.
PureTech Health Address
6 Tide Street
Boston, MA
United States

Past Companies

PureTech HealthVice President of Research
Alivio TherapeuticsVice President of Research and Development
Alivio TherapeuticsHead of Formulations Science

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.